Bair Hugger Forced Air Warming Devices

The Bair Hugger docket, built on claims that a widely used surgical forced-air warming system increases the risk of periprosthetic joint infection following orthopedic implant surgery by disrupting operating-room airflow, still carries 8,433 pending actions a decade after centralization — a large number that needs to be read against this docket's difficult general-causation history for plaintiffs, including adverse expert-admissibility rulings that narrowed the litigation's path in federal court.

For a funder, that history is essential context rather than a footnote. General-causation setbacks in a mass tort materially change the risk-return profile of financing claims in that docket: pending-action volume alone does not tell a funder how strong the underlying claims are if key expert testimony connecting the device to infection risk has faced exclusion challenges. Diligence on any Bair Hugger claim today should center specifically on the current state of causation admissibility in the relevant jurisdiction — federal MDL rulings and state-court rulings on this issue have not been uniform — rather than assuming the large pending-action count reflects strong aggregate settlement leverage.

Medical-lien considerations are meaningful here given that periprosthetic joint infection often requires additional surgery, extended antibiotic treatment, and sometimes implant revision, generating substantial associated treatment costs relative to expected recovery.

Given the causation uncertainty that has shaped this docket's trajectory, portfolio-level inventory finance requires more conservative underwriting assumptions here than in a docket with a cleaner causation record, and advance sizing should reflect that added risk rather than treating this as a straightforward high-volume mass tort. Criterica Capital's mass-tort finance line can still apply, priced to this docket's specific risk profile.

Criterica Intelligence's structural brief covers the causation-admissibility history in more depth for firms evaluating whether to bring or fund a claim in this docket.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.